Advertisement
U.S. markets closed

Passage Bio, Inc. (PASG)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Visitors trend2W10W9M
0.5795-0.0165 (-2.77%)
At close: 04:00PM EDT
0.5904 +0.01 (+1.88%)
After hours: 07:38PM EDT
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
0
0
0
0
0
-
Operating Expense
76,718
102,999
135,394
177,729
111,902
-
Operating Income
-76,718
-102,999
-135,394
-177,729
-111,902
-
Net Non Operating Interest Income Expense
-
-
2,269
343
670
696
Other Income Expense
148
937
-731
-8,000
-1,000
-
Pretax Income
-76,570
-102,062
-136,125
-185,386
-112,232
-
Net Income Common Stockholders
-76,570
-102,062
-136,125
-185,386
-112,232
-
Diluted NI Available to Com Stockholders
-76,570
-102,062
-136,125
-185,386
-112,232
-
Basic EPS
-2.05
-1.86
-2.50
-3.48
-2.46
-
Diluted EPS
-2.05
-1.86
-2.50
-3.48
-2.46
-
Basic Average Shares
54,668
54,743
54,429
53,344
45,615
-
Diluted Average Shares
54,668
54,743
54,429
53,344
45,615
-
Total Operating Income as Reported
-82,546
-108,389
-138,394
-185,729
-112,902
-
Total Expenses
76,718
102,999
135,394
177,729
111,902
-
Net Income from Continuing & Discontinued Operation
-76,570
-102,062
-136,125
-185,386
-112,232
-
Normalized Income
-70,742
-96,672
-133,125
-177,386
-111,232
-
Interest Income
-
-
2,269
343
670
696
Net Interest Income
-
-
2,269
343
670
696
EBIT
-76,718
-102,999
-135,394
-177,729
-111,902
-
EBITDA
-73,350
-99,278
-131,715
-176,186
-111,102
-
Reconciled Depreciation
3,368
3,721
3,679
1,543
800
-
Net Income from Continuing Operation Net Minority Interest
-76,570
-102,062
-136,125
-185,386
-112,232
-
Total Unusual Items Excluding Goodwill
-5,828
-5,390
-3,000
-8,000
-1,000
-
Total Unusual Items
-5,828
-5,390
-3,000
-8,000
-1,000
-
Normalized EBITDA
-67,522
-93,888
-128,715
-168,186
-110,102
-
Tax Rate for Calcs
0
0
0
0
0
-
Tax Effect of Unusual Items
0
0
0
0
0
-